Key clinical point: Treatment of Cushing’s syndrome with the glucocorticoid receptor antagonist mifepristone results in sustained significant weight loss, with its attendant cardiometabolic benefits. Major finding: More than 80% of patients with …
via Get Fit Bookmark http://ift.tt/1teZpLf
via Tumblr http://ift.tt/1mXUFT1
No comments:
Post a Comment